530 related articles for article (PubMed ID: 30578959)
21. The evolution of cellular deficiency in GATA2 mutation.
Dickinson RE; Milne P; Jardine L; Zandi S; Swierczek SI; McGovern N; Cookson S; Ferozepurwalla Z; Langridge A; Pagan S; Gennery A; Heiskanen-Kosma T; Hämäläinen S; Seppänen M; Helbert M; Tholouli E; Gambineri E; Reykdal S; Gottfreðsson M; Thaventhiran JE; Morris E; Hirschfield G; Richter AG; Jolles S; Bacon CM; Hambleton S; Haniffa M; Bryceson Y; Allen C; Prchal JT; Dick JE; Bigley V; Collin M
Blood; 2014 Feb; 123(6):863-74. PubMed ID: 24345756
[TBL] [Abstract][Full Text] [Related]
22. Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency.
Rein A; Geron I; Kugler E; Fishman H; Gottlieb E; Abramovich I; Giladi A; Amit I; Mulet-Lazaro R; Delwel R; Gröschel S; Levin-Zaidman S; Dezorella N; Holdengreber V; Rao TN; Yacobovich J; Steinberg-Shemer O; Huang QH; Tan Y; Chen SJ; Izraeli S; Birger Y
Haematologica; 2023 Sep; 108(9):2316-2330. PubMed ID: 36475518
[TBL] [Abstract][Full Text] [Related]
23. Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literature.
Gao J; Gentzler RD; Timms AE; Horwitz MS; Frankfurt O; Altman JK; Peterson LC
J Hematol Oncol; 2014 Apr; 7():36. PubMed ID: 24754962
[TBL] [Abstract][Full Text] [Related]
24. Successful umbilical cord blood hematopoietic stem cell transplantation in pediatric patients with MDS/AML associated with underlying GATA2 mutations: two case reports and review of literature.
Mallhi K; Dix DB; Niederhoffer KY; Armstrong L; Rozmus J
Pediatr Transplant; 2016 Nov; 20(7):1004-1007. PubMed ID: 27416790
[TBL] [Abstract][Full Text] [Related]
25. Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency.
Kozyra EJ; Pastor VB; Lefkopoulos S; Sahoo SS; Busch H; Voss RK; Erlacher M; Lebrecht D; Szvetnik EA; Hirabayashi S; Pasaulienė R; Pedace L; Tartaglia M; Klemann C; Metzger P; Boerries M; Catala A; Hasle H; de Haas V; Kállay K; Masetti R; De Moerloose B; Dworzak M; Schmugge M; Smith O; Starý J; Mejstrikova E; Ussowicz M; Morris E; Singh P; Collin M; Derecka M; Göhring G; Flotho C; Strahm B; Locatelli F; Niemeyer CM; Trompouki E; Wlodarski MW;
Leukemia; 2020 Oct; 34(10):2673-2687. PubMed ID: 32555368
[TBL] [Abstract][Full Text] [Related]
26. Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia.
Churpek JE; Pyrtel K; Kanchi KL; Shao J; Koboldt D; Miller CA; Shen D; Fulton R; O'Laughlin M; Fronick C; Pusic I; Uy GL; Braunstein EM; Levis M; Ross J; Elliott K; Heath S; Jiang A; Westervelt P; DiPersio JF; Link DC; Walter MJ; Welch J; Wilson R; Ley TJ; Godley LA; Graubert TA
Blood; 2015 Nov; 126(22):2484-90. PubMed ID: 26492932
[TBL] [Abstract][Full Text] [Related]
27. ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome.
West RR; Calvo KR; Embree LJ; Wang W; Tuschong LM; Bauer TR; Tillo D; Lack J; Droll S; Hsu AP; Holland SM; Hickstein DD
Blood Adv; 2022 Feb; 6(3):793-807. PubMed ID: 34529785
[TBL] [Abstract][Full Text] [Related]
28. Donor-derived MDS/AML in families with germline
Galera P; Hsu AP; Wang W; Droll S; Chen R; Schwartz JR; Klco JM; Arai S; Maese L; Zerbe C; Parta MJ; Young NS; Holland SM; Hickstein DD; Calvo KR
Blood; 2018 Nov; 132(18):1994-1998. PubMed ID: 30232126
[No Abstract] [Full Text] [Related]
29. Prevalence of germline GATA2 and SAMD9/9L variants in paediatric haematological disorders with monosomy 7.
Yoshida M; Tanase-Nakao K; Shima H; Shirai R; Yoshida K; Osumi T; Deguchi T; Mori M; Arakawa Y; Takagi M; Miyamura T; Sakaguchi K; Toyoda H; Ishida H; Sakata N; Imamura T; Kawahara Y; Morimoto A; Koike T; Yagasaki H; Ito S; Tomizawa D; Kiyokawa N; Narumi S; Kato M
Br J Haematol; 2020 Dec; 191(5):835-843. PubMed ID: 32770553
[TBL] [Abstract][Full Text] [Related]
30. GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.
Kotmayer L; Romero-Moya D; Marin-Bejar O; Kozyra E; Català A; Bigas A; Wlodarski MW; Bödör C; Giorgetti A
Br J Haematol; 2022 Nov; 199(4):482-495. PubMed ID: 35753998
[TBL] [Abstract][Full Text] [Related]
31. Successful allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms complicated with secondary pulmonary alveolar proteinosis and Behçet's disease harboring GATA2 mutation.
Sato Y; Fukatsu M; Suzuki T; Sasajima T; Gunji N; Yoshida S; Asano N; Fukuchi K; Mori H; Takano M; Hayashi K; Takahashi H; Shirado-Harada K; Kimura S; Koyama D; Migita K; Ikezoe T
Int J Hematol; 2023 Nov; 118(5):642-646. PubMed ID: 37084069
[TBL] [Abstract][Full Text] [Related]
32. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
Sahoo SS; Kozyra EJ; Wlodarski MW
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
[TBL] [Abstract][Full Text] [Related]
33. Myeloid malignancies with somatic
Alfayez M; Wang SA; Bannon SA; Kontoyiannis DP; Kornblau SM; Orange JS; Mace EM; DiNardo CD
Leuk Lymphoma; 2019 Aug; 60(8):2025-2033. PubMed ID: 30648453
[TBL] [Abstract][Full Text] [Related]
34. Somatic genetic alterations predict hematological progression in GATA2 deficiency.
Largeaud L; Collin M; Monselet N; Vergez F; Fregona V; Larcher L; Hirsch P; Duployez N; Bidet A; Luquet I; Bustamante J; Dufrechou S; Prade N; Nolla M; Hamelle C; Tavitian S; Habib C; Meynier M; Bellanne-Chantelot C; Donadieu J; De Fontbrune FS; Fieschi C; Ferster A; Delhommeau F; Delabesse E; Pasquet M
Haematologica; 2023 Jun; 108(6):1515-1529. PubMed ID: 36727400
[TBL] [Abstract][Full Text] [Related]
35. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes.
Sahoo SS; Pastor VB; Goodings C; Voss RK; Kozyra EJ; Szvetnik A; Noellke P; Dworzak M; Starý J; Locatelli F; Masetti R; Schmugge M; De Moerloose B; Catala A; Kállay K; Turkiewicz D; Hasle H; Buechner J; Jahnukainen K; Ussowicz M; Polychronopoulou S; Smith OP; Fabri O; Barzilai S; de Haas V; Baumann I; Schwarz-Furlan S; ; Niewisch MR; Sauer MG; Burkhardt B; Lang P; Bader P; Beier R; Müller I; Albert MH; Meisel R; Schulz A; Cario G; Panda PK; Wehrle J; Hirabayashi S; Derecka M; Durruthy-Durruthy R; Göhring G; Yoshimi-Noellke A; Ku M; Lebrecht D; Erlacher M; Flotho C; Strahm B; Niemeyer CM; Wlodarski MW
Nat Med; 2021 Oct; 27(10):1806-1817. PubMed ID: 34621053
[TBL] [Abstract][Full Text] [Related]
36. [Predisposition and progression of myelodysplastic syndromes].
Makishima H
Rinsho Ketsueki; 2021; 62(4):278-288. PubMed ID: 33967153
[TBL] [Abstract][Full Text] [Related]
37. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival.
Bödör C; Renneville A; Smith M; Charazac A; Iqbal S; Etancelin P; Cavenagh J; Barnett MJ; Kramarzová K; Krishnan B; Matolcsy A; Preudhomme C; Fitzgibbon J; Owen C
Haematologica; 2012 Jun; 97(6):890-4. PubMed ID: 22271902
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic heterogeneity associated with germline
Haddox CL; Carr RM; Abraham RS; Perez Botero J; Rodriguez V; Pardanani A; Patnaik MM
Leuk Lymphoma; 2019 Dec; 60(13):3282-3286. PubMed ID: 31246134
[No Abstract] [Full Text] [Related]
39. GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia.
Ganapathi KA; Townsley DM; Hsu AP; Arthur DC; Zerbe CS; Cuellar-Rodriguez J; Hickstein DD; Rosenzweig SD; Braylan RC; Young NS; Holland SM; Calvo KR
Blood; 2015 Jan; 125(1):56-70. PubMed ID: 25359990
[TBL] [Abstract][Full Text] [Related]
40. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
Galera P; Dulau-Florea A; Calvo KR
Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
